Ezetimibe does not disturb glycaemic control
Peter Toth (Sterling Rock Falls Clinic, Sterling, IL, USA)
Recorded at ISA2015, Amsterdam, The Netherlands on May 24-26, 2015
ISA2015 | Clinical Breakthroughs Peter Toth presented data of a pooled analysis of clinical trials, in which no evidence was seen that ezetimibe increases fasting glucose, as opposed to statins.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.